Back to HomeBeta

ICD-10 Coding for Urothelial Carcinoma of the Bladder(C67.0, C67.9)

Complete ICD-10-CM coding and documentation guide for Urothelial Carcinoma of the Bladder. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Transitional Cell Carcinoma of the BladderBladder Cancer

Related ICD-10 Code Ranges

Complete code families applicable to Urothelial Carcinoma of the Bladder

C67.0-C67.9Primary Range

Malignant neoplasm of bladder

This range includes codes for specific subsites of bladder cancer, which are critical for accurate diagnosis and treatment planning.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C67.0Malignant neoplasm of trigone of bladderUse when the tumor is specifically located at the trigone of the bladder.
  • Operative report specifying tumor location at trigone
  • Pathology report confirming malignant neoplasm
C67.9Malignant neoplasm of bladder, unspecifiedUse when the specific subsite of the bladder is not documented.
  • Lack of specific subsite documentation
  • Pathology report confirming malignant neoplasm

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for urothelial carcinoma of bladder

Essential facts and insights about Urothelial Carcinoma of the Bladder

The ICD-10 code for urothelial carcinoma of the bladder varies by subsite, such as C67.0 for trigone and C67.9 for unspecified.

Primary ICD-10-CM Codes for urothelial carcinoma of bladder

Malignant neoplasm of trigone of bladder
Billable Code

Decision Criteria

clinical Criteria

  • Tumor located at trigone

Applicable To

  • Cancer of the trigone of the bladder

Excludes

  • Benign neoplasm of bladder (D30.3)

Clinical Validation Requirements

  • Operative report specifying tumor location at trigone
  • Pathology report confirming malignant neoplasm

Code-Specific Risks

  • Misidentifying the tumor location can lead to incorrect coding.

Coding Notes

  • Ensure the specific subsite is documented to avoid using the unspecified code.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of malignant neoplasm of bladder

Z85.51
Use for patients with a history of bladder cancer.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of bladder, unspecified

C67.9
Use C67.9 when the specific subsite of the bladder is not documented.

Malignant neoplasm of trigone of bladder

C67.0
Use C67.0 when the tumor is specifically located at the trigone.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Urothelial Carcinoma of the Bladder to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C67.0.

Impact

Clinical: May affect treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential for incorrect billing and reimbursement.

Mitigation Strategy

Ensure detailed operative notes, Cross-check pathology reports

Impact

Reimbursement: May lead to incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases specificity and accuracy of clinical data.

Mitigation Strategy

Ensure documentation specifies the exact subsite of the tumor.

Impact

Failure to document specific subsite can lead to audit issues.

Mitigation Strategy

Implement thorough documentation protocols.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Urothelial Carcinoma of the Bladder, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Urothelial Carcinoma of the Bladder

Use these documentation templates to ensure complete and accurate documentation for Urothelial Carcinoma of the Bladder. These templates include all required elements for proper coding and billing.

Bladder cancer diagnosis

Specialty: Urology

Required Elements

  • Tumor location
  • Histology
  • Invasion depth
  • Presence of muscularis propria

Example Documentation

High-grade papillary urothelial carcinoma involving the left lateral wall with invasion into lamina propria.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Bladder cancer identified
Good Documentation Example
High-grade papillary urothelial carcinoma (8120/3) involving lateral wall (C67.2) with focal invasion into lamina propria.
Explanation
The good example provides specific location and histological details necessary for accurate coding.

Need help with ICD-10 coding for Urothelial Carcinoma of the Bladder? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more